Study on the mechanism of zinc deficiency and hyperglycemia based on multi-omics integrated analysis of blood, live and skeletal muscle

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200064096

Enrollment

Unknown

Registered

2022-09-26

Start date

2022-10-01

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Zinc deficiency and hyperglycemia

Interventions

Normal control group:Nothing

Zinc supplementation intervention group in early stage of diabetes:Zinc gluconate oral liquid 24ml, zinc content about 12mg/d

Pre diabetes placebo group:Equal volume glucose oral liquid

Eligibility

Sex/Gender

All

Age

35 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Adult residents aged 35 to 74 (considering the impact of living place on dietary habits, the respondents are required to live in different places for at least 10 years); 2. Voluntarily participate and have signed the informed consent form.

Exclusion criteria

Exclusion criteria: Have been diagnosed with cancer, hereditary diseases, hyperthyroidism, psychosis and type 1 diabetes; Heart, liver, kidney and other functional failure and physical disability can not walk normally.

Design outcomes

Primary

Measure	Time frame
Serum zinc;Fasting blood glucose;Insulin;Glucagon;Glycosylated hemoglobin;Cholesterol;Triglyceride;High density lipoprotein;Low density lipoprotein;Free fatty acids;	—

Countries

China

Contacts

Public ContactMaoqing Wang

Department of Nutrition and Food, School of Public Health, Harbin Medical University, Nangang District, Harbin, Heilongjiang

wang_maoqing@126.com0451-87502876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026